296

  • Web Address
  • DOI
  • Date of creation in the UzSCI system 24-10-2019
  • Read count 249
  • Date of publication 30-04-2016
  • Main LanguageRus
  • Pages173-176
Tags
№ Author name position Name of organisation
1 Shavazi N.M.
2 Lim M.V.
№ Name of reference
1 1. Алямовская Г.А., Кешишян Е.С. Опыт применения паливизумаба для профилактики респираторно-синцитиальной вирусной инфекции у недоношенных детей с бронхолегочной дисплазией. Вестник Российской Академии медицинских наук. 2012.-N 12.-С.30-34 2. Бронхиты и бронхиолиты. Острые обструктивные состояния дыхательных путей у детей. Научно-информативный материал. Москва 2011. С. 198. 3. Делягин В.М. Острый бронхиолит у детей. Медицинский совет. №1, Часть 3, В детской поликлинике. С.64-68. 2013 4. Куличенко Т. В. Паливизумаб: новые возможности профилактики тяжелых форм РСвирусной инфекции у детей. Педиатрическая фармакология. № 4 / том 7. 2010 5. Симонова О.И., Горинова Ю.В., Бакрадзе М.Д. Эффективность ингаляций гипертонического раствора у детей с бронхитами и бронхиолитами. Вопросы современной педиатрии /2014/ том 13/ № 4 6. Смирнов В.С. Современные средства профилактики и лечения гриппа и ОРВИ. Фарминдекс, Санкт-Петербург 2008 7. Шамсиев Ф.М., Хайдарова М.М., Мовланова Ш.С. Бронхиты у детей (этиология, патогенез, клиника, диагностика и лечение). Ташкент 2013. С.114. 8. American Academy of Pediatrics, Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006; 118(4):1774–93 9. Bronchiolitis Guideline Team, Cincinnati Children’s Hospital Medical Center, November 2010 Evidence-based care guideline for management of bronchiolitis in infants one year of age or less with a first time episode. pp. 1 16. www. cincinnatichildrens.org/WorkArea/DownloadAsset.aspx?id= 87885 (Accessed September 24, 2014). 10. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005;365(9465):1147-52. 39 11. DeNicola L. Pediatric Bronchiolitis. URL: http://emedicine.medscape.com/ article /961963overview 12. Destino L, Weisgerber MC, Soung P, et al. Validity of respiratory scores in bronchiolitis. Hosp Pediatr.2012;2(4):202–9. 13. Everard ML, Bara A, Kurian M, et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2005;3:CD001279. 46 14. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98. 15. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2011;6:CD003123. 49 16. Henrickson KJ. Advances in the laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J.2004;23(1 Suppl):S6–10. 17. Hilliard TN, Archer N, Laura H, et al. Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child. 2012;97(2):182–3. 18. Horn S., Smout R. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. // J. Pediatrics, 2003. – v. 143. – S.133141. 19. Isaacs D., Dickson H., O'Callaghan C. et al. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. // Arch. Dis. Child., 1991. – v. 66. – pp. 227-231 20. Lieberthal A., Bauchner H., Hall C., et al. Diagnosis and Management of Bronchiolitis // Pediatrics. 2006. V. 118. P. 1774–1793. 21. Nagakumar P, DoullI. Current therapy for bronchiolitis. Arch Dis Child. 2012 Jun 25. [Epub ahead of print]. 44 22. Paranhos-Baccalà G, Komurian-Pradel F, Richard N, Vernet G, Lina B, Floret D. Mixed respiratory virus infections. J Clin Virol. 2008;43(4):407–10. 23. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2007;1:CD004873. 45 24. Shadman KA, Wald ER. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther 2011;11(11):1455-67. Epub 2011 Aug 11. 43 25. Tal G, Cesar K, Oron A, Houri S, et al. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J 2006;8(3):169-73. 48 26. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. // Arch. Dis. Child., 2009. – v. 94. – pp. 99-103. 27. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007;1:CD000181. 42 28. Wainwright C. Acute viral bronchiolitis in children: A very common condition with few therapeutic options. Paediatr Respir Rev. 2010;11(1):3937– 45.quiz
Waiting